- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain A: K.310, P.600, G.601, N.603, T.604
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: E.281, N.282
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: G.339, E.340, N.343
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: D.796
- Chain B: N.709, G.1131
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: A.706, N.1074
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: H.655, N.657
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.616, Q.644
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.122, T.124, F.157
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: G.339, E.340, N.343
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: D.796
- Chain C: N.709, N.710, G.1131
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain C: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: N.603, T.604
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: E.281, N.282
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.122
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: G.339, E.340, N.343
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milazzo, F.M. et al., Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery. Mol.Ther. (2022)
- Release Date
- 2022-10-12
- Peptides
- Spike glycoprotein,Fibritin: ABC
scFv76 single chain fragment: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EE
FF
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milazzo, F.M. et al., Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery. Mol.Ther. (2022)
- Release Date
- 2022-10-12
- Peptides
- Spike glycoprotein,Fibritin: ABC
scFv76 single chain fragment: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EE
FF
G